お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
997575

トランスフェクション試薬および機器の世界市場

Transfection Reagents and Equipment

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 240 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.20円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

トランスフェクション試薬および機器の世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 240 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のトランスフェクション試薬および機器の市場規模は、分析期間(2020年~2027年)に6%のCAGRで成長する見通しで、2020年の8億4,860万米ドルから、2027年には13億米ドルに達すると予測されています。

当レポートで分析されているセグメントの1つであるトランスフェクション試薬は、分析期間中に6.5%のCAGRで成長し、7億1,840万米ドルに達すると予測されています。

当レポートは、世界のトランスフェクション試薬および機器市場について調査しており、市場シェア、Covid-19の影響、動向や成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Life Technologies Corporation
  • Lonza Group AG
  • MilliporeSigma
  • PolyPlus Battery Company (PPBC)
  • Promega Corporation
  • Qiagen NV
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.

目次

I. 調査手法

II. エグゼクティブサマリー

  • 市場概要
    • インフルエンサー市場の洞察
    • 世界市場の軌跡
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と推進要因
  • 世界市場の見通し

III. 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

IV. 競合

  • 企業プロファイル:42社
目次
Product Code: MCP15289

Abstract:

Global Transfection Reagents and Equipment Market to Reach $1.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Transfection Reagents and Equipment estimated at US$848.6 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at aCAGR of 6% over the period 2020-2027. Transfection reagents, one of the segments analyzed in the report, is projected to record 6.5% CAGR and reach US$718.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Transfection equipment segment is readjusted to a revised 5.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $250.4 Million, While China is Forecast to Grow at 5.6% CAGR

The Transfection Reagents and Equipment market in the U.S. is estimated at US$250.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$223.7 Million by the year 2027 trailing a CAGR of 5.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Select Competitors (Total 42 Featured) -

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Life Technologies Corporation
  • Lonza Group AG
  • MilliporeSigma
  • PolyPlus Battery Company (PPBC)
  • Promega Corporation
  • Qiagen NV
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Transfection Reagents and Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Transfection Reagents and Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Transfection Reagents and Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Transfection reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Transfection reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Transfection reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Transfection equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Transfection equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Transfection equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Electroporation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Electroporation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Electroporation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Liposomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Particle Bombardment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Particle Bombardment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Particle Bombardment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Microinjection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Adenoviral Vectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Adenoviral Vectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Adenoviral Vectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Other Equipment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Other Equipment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other Equipment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Gene Expression Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Gene Expression Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Gene Expression Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: World 15-Year Perspective for Protein Production by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Transgenic Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 35: World Historic Review for Transgenic Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: World 15-Year Perspective for Transgenic Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 37: World Current & Future Analysis for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 38: World Historic Review for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: World 15-Year Perspective for Therapeutic Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 40: World Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 41: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: World 15-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 43: World Current & Future Analysis for Biomedical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 44: World Historic Review for Biomedical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: World 15-Year Perspective for Biomedical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 46: USA Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: USA Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: USA 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 49: USA Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: USA Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: USA 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 52: USA Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: USA Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: USA 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 55: Canada Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Canada Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Canada 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 58: Canada Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Canada Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Canada 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 61: Canada Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Canada Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Canada 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 64: Japan Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Japan Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Japan 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 67: Japan Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Japan Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Japan 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 70: Japan Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Japan Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Japan 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 73: China Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: China Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: China 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 76: China Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: China Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: China 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 79: China Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: China Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: China 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 82: Europe Current & Future Analysis for Transfection Reagents and Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 83: Europe Historic Review for Transfection Reagents and Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Europe 15-Year Perspective for Transfection Reagents and Equipment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 85: Europe Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Europe Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Europe 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 88: Europe Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Europe Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Europe 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 91: Europe Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Europe Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Europe 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 94: France Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: France Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: France 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 97: France Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: France Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: France 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 100: France Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: France Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: France 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 103: Germany Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Germany Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Germany 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 106: Germany Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Germany Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Germany 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 109: Germany Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Germany Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: Germany 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 112: Italy Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Italy Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Italy 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 115: Italy Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Italy Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Italy 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 118: Italy Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Italy Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Italy 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 121: UK Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: UK Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: UK 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 124: UK Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: UK Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: UK 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 127: UK Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: UK Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: UK 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 130: Rest of Europe Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Europe Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Europe 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 133: Rest of Europe Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 139: Asia-Pacific Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Asia-Pacific 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 142: Asia-Pacific Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 148: Rest of World Current & Future Analysis for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Rest of World Historic Review for Transfection Reagents and Equipment by Market Segment - Transfection reagents and Transfection equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Rest of World 15-Year Perspective for Transfection Reagents and Equipment by Market Segment - Percentage Breakdown of Value Sales for Transfection reagents and Transfection equipment for the Years 2012, 2020 & 2027
    • TABLE 151: Rest of World Current & Future Analysis for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Rest of World Historic Review for Transfection Reagents and Equipment by Equipment Type - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Rest of World 15-Year Perspective for Transfection Reagents and Equipment by Equipment Type - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors and Other Equipment Types for the Years 2012, 2020 & 2027
    • TABLE 154: Rest of World Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Rest of World Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Rest of World 15-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery, Cancer Research and Biomedical Research for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 42
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.